MedTrace Logo

Teledermatology Mobile App: Patient Facing

NCT03241589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 466

Last updated 2023-07-27

Study results available
· View outcomes & findings →

Summary

This study was designed to measure the impact of two teledermatology apps to provide direct to patient teledermatology follow up care, Patient Viewer and My VA Images, with a trial on access to dermatology care. The overall hypothesis was that sites implementing Department of Veterans Affairs' (VA) teledermatology mobile apps would significantly augment the use of teledermatology and improve Veterans' access to skin care relative to control sites. Specifically, the investigators hypothesized that these apps would improve established patients' ability to follow-up with dermatology care remotely, reducing patient travel to dermatology clinics while opening up dermatology clinic space for other patients. Due to a lack of participation by sites during the study which was conducted during the novel coronavirus (COVID-19) pandemic, the groups examined are Veterans who live in rural areas compared to those in urban areas.

Previously the study included a parallel trial to evaluate another teledermatology mobile app, VA Telederm. This trial was no longer feasible within this study's funding timeline due to limitations imposed on the mobile app by Office of Information \& Technology that were not under the control of the PI or the operational partner, Office of Connected Care (OCC).

Conditions

  • Introduction of Teledermatology Mobile Apps

Interventions

OTHER

Direct to patient facing mobile apps introduction

VA employees and Veterans begin use of OCC's direct to patient facing mobile app.

Sponsors & Collaborators

Principal Investigators

  • Dennis H. Oh, MD PhD · San Francisco VA Medical Center, San Francisco, CA

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-13
Primary Completion
2020-09-30
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03241589 on ClinicalTrials.gov